CEO LEADERSHIP SERIES

ASHTON TWEED'S CEO INTERVIEWS

July 24, 2022

Orthotic Holdings CEO: How to Strengthen a Life Sciences Platform Company During COVID-19

Paul Joyce, CEO Orthotic Holdings Inc. Before he accepted the CEO position at Orthotic Holdings Inc. (OHI), Paul Joyce had no idea he was using an […]
September 29, 2021

CEO of Osmol Therapeutics Leads Virtual Charge to Develop Ground-Breaking Treatment to Prevent Chemo Side-Effects

April 6, 2021

First-Time CEO Takes on COVID-19 Shutdown in First Weeks at Ascend Therapeutics

Nicholas Hart President and CEO of Ascend Therapeutics When Nicholas Hart joined Ascend Therapeutics, a pharmaceutical company specializing in women’s health, in January 2020, he was […]
January 14, 2021

Scynexis CEO Shares Strategies for Reorganizing, Refocusing Biopharma Company

Marco Taglietti, M.D. President and CEO of Scynexis When Marco Taglietti, M.D., decided to retire in 2014 at age 55, it was after a long and […]
November 9, 2020

CEO Leadership Series: A Biopharma Executive’s Next Act in Developing Life-Changing Treatments

When Susan Dillon co-founded Aro Biotherapeutics in 2018, she had already led teams of researchers at Johnson & Johnson to develop revolutionary drugs for autoimmune diseases—Remicade®, Simponi, Stelara® and Tremfya®.
October 2, 2020

CEO Leadership Series: Jie Du, Ph.D., Former CEO & President, JDP Therapeutics Inc.

HOW TO SUCCEED WITH A PHARMA STARTUP WHEN YOU’RE ON YOUR OWN Dr. Jie Du had a unique problem when it came to fundraising for her […]
August 21, 2020

CEO Leadership Series: David Baker, CEO, Vallon Pharmaceuticals

DEVELOPING A NOVEL SOLUTION FOR A GROWING PROBLEM A drug crisis has been quietly growing that many people may not be aware of—the abuse of stimulant […]
July 10, 2020

CEO Leadership Series: 5 Female Leaders Reveal What They Really Think About Gender Discrimination, Diversity Efforts and #MeToo—Part 2

May 31, 2020

CEO Leadership Series: 5 Female Leaders Reveal What They Really Think About Gender Discrimination, Diversity Efforts and #MeToo—Part 1

April 27, 2020

CEO Leadership Series: Stella Vnook, CEO, Diverse Biotech Inc.

PERSONAL INVESTMENT HELPS DRIVE NEW CANCER THERAPY DEVELOPMENT When Stella Vnook became CEO of Diverse Biotech Inc. in mid-2019, she welcomed the challenge of guiding the […]
January 24, 2020

CEO Leadership Series: Suman Shirodkar, CEO, Cambridge Epigenetix

CHANGING THE PARADIGM OF CANCER DIAGNOSIS When Suman Shirodkar, MBBS, Ph.D., became the CEO of Cambridge Epigenetix Ltd. in 2018, she brought several decades of diverse […]
December 6, 2019

CEO Leadership Series: Martin Lehr, CEO & Co-Founder, Context Therapeutics

A NEW POINT OF VIEW LEADS TO A POTENTIAL NEW TREATMENT When venture capitalist Martin Lehr decided he wanted a better understanding of the biopharma companies […]
August 22, 2019

CEO Leadership Series: Fred Toney, CEO, Launchpad Digital Health

STARTUP MENTOR SAYS IT’S ALL ABOUT THE TEAM After spending years guiding healthcare companies as the top financial executive, Fred Toney now helps entrepreneurs build their […]
June 7, 2019

CEO Leadership Series: Foad Dabiri, CEO, Wanda Inc.

A DATA-DRIVEN APPROACH TO IMPROVING HEALTHCARE For Foad Dabiri, CEO of Wanda Inc., improving health care is all about the numbers. He and his team have […]
March 22, 2019

CEO Leadership Series: Ed Seguine, CEO, Clinical Ink

HOW A CLINICAL TRIAL TECH COMPANY BALANCES GROWTH AND BUILDS CREDIBILITY Clinical Ink, a global clinical trial technology company based in Horsham, PA., is on a […]
portrait of a businessman and a businesswoman leader

ARE YOU A CEO INTERESTED IN JOINING OUR LEADERSHIP SERIES?

CONTACT US TO DISCUSS AN INTERVIEW:

Jordan Warshafsky
Partner, Ashton Tweed Ltd.
Email: JWarshafsky@ashtontweed.com
Phone: 610.725.0290 x441

Ashton Tweed, Ltd.
314 S. Henderson Rd.
Suite G370
King of Prussia, PA 19406